Literature DB >> 26785644

Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.

Hayley Goullee1, Antonia L Wadley2, Catherine L Cherry2,3, Richard J N Allcock1, Michael Black4, Peter R Kamerman2, Patricia Price5,6.   

Abstract

HIV-associated sensory neuropathy (HIV-SN) is the most common neurological condition associated with HIV. HIV-SN has characteristics of an inflammatory pathology caused by the virus itself and/or by antiretroviral treatment (ART). Here, we assess the impact of single-nucleotide polymorphisms (SNPs) in a cluster of three genes that affect inflammation and neuronal repair: P2X7R, P2X4R and CAMKK2. HIV-SN status was assessed using the Brief Peripheral Neuropathy Screening tool, with SN defined by bilateral symptoms and signs. Forty-five SNPs in P2X7R, P2X4R and CAMKK2 were genotyped using TaqMan fluorescent probes, in DNA samples from 153 HIV(+) black Southern African patients exposed to stavudine. Haplotypes were derived using the fastPHASE algorithm, and SNP genotypes and haplotypes associated with HIV-SN were identified. Optimal logistic regression models included demographics (age and height), with SNPs (model p < 0.0001; R (2) = 0.19) or haplotypes (model p < 0.0001; R (2) = 0.18, n = 137 excluding patients carrying CAMKK2 haplotypes perfectly associated with SN). Overall, CAMKK2 exhibited the strongest associations with HIV-SN, with two SNPs and six haplotypes predicting SN status in black Southern Africans. This gene warrants further study.

Entities:  

Keywords:  CAMKK2; HIV; P2X4R; P2X7R; Sensory neuropathy

Mesh:

Substances:

Year:  2016        PMID: 26785644     DOI: 10.1007/s13365-015-0421-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  43 in total

1.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

Authors:  Ronald J Ellis; Debralee Rosario; David B Clifford; Justin C McArthur; David Simpson; Terry Alexander; Benjamin B Gelman; Florin Vaida; Ann Collier; Christina M Marra; Beau Ances; J Hampton Atkinson; Robert H Dworkin; Susan Morgello; Igor Grant
Journal:  Arch Neurol       Date:  2010-05

Review 2.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

3.  Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit.

Authors:  Emer M Garry; Andrew Moss; Roberta Rosie; Ada Delaney; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Mol Cell Neurosci       Date:  2003-09       Impact factor: 4.314

4.  Combinations of TLR and NOD2 ligands stimulate rat microglial P2X4R expression.

Authors:  Liang-Hao Guo; Ke-Tai Guo; Hans Peter Wendel; Hermann J Schluesener
Journal:  Biochem Biophys Res Commun       Date:  2006-09-01       Impact factor: 3.575

5.  Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.

Authors:  Catherine L Cherry; Steven L Wesselingh; Luxshimi Lal; Justin C McArthur
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

Review 6.  Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.

Authors:  Peter R Kamerman; Philippa J Moss; Juliane Weber; Victoria C J Wallace; Andrew S C Rice; Wenlong Huang
Journal:  J Peripher Nerv Syst       Date:  2012-03       Impact factor: 3.494

7.  Gain-of-function of P2X7 receptor gene variants in multiple sclerosis.

Authors:  Olatz Oyanguren-Desez; Alfredo Rodríguez-Antigüedad; Pablo Villoslada; María Domercq; Elena Alberdi; Carlos Matute
Journal:  Cell Calcium       Date:  2011-09-08       Impact factor: 6.817

8.  P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats.

Authors:  Sheng Chen; Qingyi Ma; Paul R Krafft; Yujie Chen; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

9.  HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.

Authors:  Tribhuvan Nath Dubey; Somnath Singh Raghuvanshi; Himanshu Sharma; Rita Saxena
Journal:  Neurol India       Date:  2013 Sep-Oct       Impact factor: 2.117

Review 10.  Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy.

Authors:  W R Tyor; S L Wesselingh; J W Griffin; J C McArthur; D E Griffin
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-08-01
View more
  11 in total

1.  A complete map of the Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) signaling pathway.

Authors:  Mohd Altaf Najar; D A B Rex; Prashant Kumar Modi; Nupur Agarwal; Shobha Dagamajalu; Gayathree Karthikkeyan; Manavalan Vijayakumar; Aditi Chatterjee; Uma Sankar; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

2.  Polymorphisms in CAMKK2 associate with susceptibility to sensory neuropathy in HIV patients treated without stavudine.

Authors:  Jessica Gaff; Fitri Octaviana; Ibnu Ariyanto; Catherine Cherry; Simon M Laws; Patricia Price
Journal:  J Neurovirol       Date:  2019-07-15       Impact factor: 2.643

3.  A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease.

Authors:  Samuel Halstrom; Catherine L Cherry; Michael Black; Rachel Thomson; Hayley Goullee; Svetlana Baltic; Richard Allcock; Suzanna E L Temple; Patricia Price
Journal:  Immunogenetics       Date:  2017-02-23       Impact factor: 2.846

4.  HIV-related Neuropathy: Pathophysiology, Treatment and Challenges.

Authors:  Noushin Jazebi; Chad Evans; Hima S Kadaru; Divya Kompella; Mukaila Raji; Felix Fang; Miguel Pappolla; Shao-Jun Tang; Jin Mo Chung; Bruce Hammock; Xiang Fang
Journal:  J Neurol Exp Neurosci       Date:  2021-02-06

Review 5.  The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus.

Authors:  Daniela D'Amico; Silvana Valdebenito; Eliseo A Eugenin
Journal:  Purinergic Signal       Date:  2021-09-20       Impact factor: 3.765

Review 6.  Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment.

Authors:  Lakshya Motwani; Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman
Journal:  Cureus       Date:  2022-06-13

Review 7.  Genetics of HIV-associated sensory neuropathy and related pain in Africans.

Authors:  Huguette Gaelle Ngassa Mbenda; Antonia Wadley; Zane Lombard; Catherine Cherry; Patricia Price; Peter Kamerman
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

8.  Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy.

Authors:  Rachel Wodarski; Deniz Bagdas; Jason J Paris; Tim Pheby; Wisam Toma; Ruqiang Xu; M Imad Damaj; Pamela E Knapp; Andrew S C Rice; Kurt F Hauser
Journal:  Pain Rep       Date:  2018-05-14

9.  Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.

Authors:  Peter Puplampu; Vincent Ganu; Ernest Kenu; William Kudzi; Patrick Adjei; Leticia Grize; Michael Käser
Journal:  J Neurovirol       Date:  2019-04-26       Impact factor: 2.643

10.  Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy.

Authors:  Marvin Blessings Moketla; Antonia L Wadley; Peter Kamerman; Debra de Assis Rosa
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.